---
title: "HPGC Renmintongtai Pharmaceutical Corporation (600829.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/600829.SH.md"
symbol: "600829.SH"
name: "HPGC Renmintongtai Pharmaceutical Corporation"
industry: "Health Care Distributors"
---

# HPGC Renmintongtai Pharmaceutical Corporation (600829.SH)

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Location | CN Market |
| Website | [www.hyrmtt.com.cn](https://www.hyrmtt.com.cn) |

## Company Profile

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemica...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:09.000Z

**Overall: C (0.45)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 14 / 25 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.26% |  |
| Net Profit YoY | -53.75% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.07 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6.20B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 10.22B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.06% | C |
| Profit Margin | 1.17% | C |
| Gross Margin | 8.11% | E |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.26% | D |
| Net Profit YoY | -53.75% | D |
| Total Assets YoY | -0.13% | D |
| Net Assets YoY | 4.14% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 8574.57% | A |
| OCF YoY | -0.26% | D |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.45 | A |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 57.38% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - HPGC Renmintongtai Pharmaceutical Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.06%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "1.17%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "8.11%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.26%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-53.75%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.13%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.14%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "8574.57%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-0.26%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.45",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "57.38%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | HUADONG MEDICINE (SZ.000963) | B | C | A | B | B | B |
| 02 | Jointown (SH.600998) | C | B | A | D | B | B |
| 03 | SINOPHARM(CNCM LTD) (SH.600511) | C | C | A | C | B | B |
| 04 | Shanghai Pharma (SH.601607) | C | C | A | D | B | C |
| 05 | GYBYS (SH.600332) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 52.03 | 16/26 | 54.95 | 30.48 | 23.26 |
| PB | 2.07 | 17/26 | 2.19 | 1.64 | 1.49 |
| PS (TTM) | 0.61 | 15/26 | 0.64 | 0.47 | 0.43 |
| Dividend Yield | 0.00% | - | 1.98% | 1.92% | 1.76% |

## References

- [Company Overview](https://longbridge.com/en/quote/600829.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/600829.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/600829.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.